EvaluatePharma is the leader in consensus forecasts of leading industry analysts and analysis of the pharmaceutical and biotechnology healthcare sectors. Information includes sales by indication, licensing deals, merger & acquisitions, venture financing, IPOs, and orphaned drugs.
Technical Notes:Accounts must be requested from EvaluatePharma. Details available after iMpact login.
ABI/INFORM contains articles from thousands of newspapers and key business magazines such as the Wall Street Journal, Financial Times, Barron’s, the Economist, and the New York Times. It also contains papers from leading academic journals across all major business disciplines.